EHA 2026 | Entretien avec le professeur Wang Liang de l’hôpital Tongren de Pékin, Université de médecine de la capitale : La thérapie CAR-T à double cible CD19/CD22 représente une avancée majeure pour le lymphome diffus à grandes cellules B récidivant ou réfractaire – MedSci
EHA 2026 | 专访首都医科大学附属北京同仁医院王亮教授：CD19/CD22 双靶点 CAR-T 为复发/难治大 B 细胞淋巴瘤带来新突破 梅斯医学 MedSci
Contenu integral de l article
{{ if item. readStatus! = 1 }} {{/if}} {{ if item. readStatus == 1 }} {{/if}} {{ if item. hrefUrl }} {{item. messageTitle}} {{else}} {{item. messageTitle}} {{/if}} {{ if item. hrefUrl || {{ if item. messageContent. length < 60 }} Développer {{else}} Développer {{/if}} Réduire {{ if item. hrefUrl }} {{item. messageContent}} {{else}} {{item. messageContent}} {{/if}} {{ item. cardName }} {{if item. expired}} Expiré {{else}} {{ item. endTime. split(' ') }} Expiré {{/if}} {{if item. expired}} {{else}} {{if item. propertyName == 'Course Membership'}} {{else}} {{/if}} {{/if}} {{if item. expired}} {{else}} {{/if}}
Questions frequentes
Which products are related to this article?
No strongly related product has been identified yet. The match updates automatically when the article or catalog changes.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
